Rare diseases
Investigational molecules
Locations
Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus
FranceA Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors
FranceA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
FranceA Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy
FranceStudy of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment
FranceA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
FranceA Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy
FranceTesting WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
FranceTesting sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer
FranceA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
FranceA Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema
FranceFranceTell us about your condition – we search every trial in Europe and connect you with the right site.
